HOME >> BIOLOGY >> NEWS
Chernobyl study: Risk of thyroid cancer rises with radiation dose

t and supplies, and then figuring out a way to maintain them without the standard resources that one takes for granted in the United States.

"It's been a long haul and an enormous amount of time and work," Davis said, whose 30-plus trips to the former Soviet Union include walking the grounds of the evacuated plant and surveying the desolated 30-kilometer evacuation zone.

Once the team established the capability to do the research, the group began its studies of thyroid cancer, a disease linked to radiation exposure. By the early 1990s, many new cases of the disease, particularly among young children, were diagnosed in regions near the blast. Since then, reports show several hundred cases of thyroid cancer in young children in the three countries contaminated by Chernobyl, a trend that appears to be continuing.

Despite the lack of resources available to initiate these studies, Davis said that scientists and citizens of the three countries were eager for the research from the start. "Our collaborators in Russia have been terrific colleagues," he said. "We now have very close ties with our partner institutions."

He also credited the strong encouragement and support from Fred Hutchinson's senior administration for helping him establish stable working relationships with their overseas colleagues.

"The incredible support and flexibility of the center, especially in the early stages, really made this happen. That can't be overstated," Davis said.


'"/>

Contact: Kristen Lidke Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
1-Sep-2004


Page: 1 2 3 4 5 6

Related biology news :

1. Amorous worms reveal effects of Chernobyl
2. Echinacea Symposium Presents New Research On Chernobyl Victims
3. United States And Ukrainian Governments Establish Permanent Chernobyl Laboratory
4. UW study: Migrating birds offer insight into sleep
5. UF study: Barren Siberia, of all places, may be original home to animal life
6. Comprehensive study: We know little about environmental effects on kids
7. UW study: Babys face lights up emotional center of new moms brain
8. UF study: World shark attacks sink again, may signal long-term trend
9. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
10. New study: percentage of babies born with intestinal birth defect growing in U.S., N.C.
11. MIT study: Hydrogen car no environmental panacea

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
(Date:2/7/2017)... Ind. , Feb. 7, 2017 Zimmer ... leader in musculoskeletal healthcare, will present at the LEERINK ... New York Palace Hotel on Wednesday, February 15, 2017 ... live webcast of the presentation can be accessed at ... replay following the conference via Zimmer Biomet,s Investor Relations ...
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
Breaking Biology News(10 mins):
(Date:2/22/2017)... ... February 22, 2017 , ... ProMIS Neurosciences (“ProMIS” or the ... diseases, today announced it has issued a scientific white paper entitled “Results from ... series of commentaries from ProMIS’s scientific team offering insight into the Company’s product ...
(Date:2/22/2017)... Origin (Origin Agritech, LLC, a subsidiary of Origin Agritech ... Arcadia (Arcadia Biosciences, Inc., NASDAQ: RKDA), a ... productivity traits and nutritional products, today announced their collaboration to achieve ... China to the United States ... ...
(Date:2/22/2017)... and SAN DIEGO , Feb. ... "Company") (OTCQB:CELZ) announced today expansion of its translational ... cell product through establishment of laboratory facilities in ... at the San Diego BioLabs facility, a biotechnology ... Novartis, and Sanofi. In November 2016, ...
(Date:2/21/2017)... ... February 21, 2017 , ... During HIMSS 2017, ... health applications, announced a partnership with Redox, a leader in cloud-based healthcare integration ... clinical systems while keeping data secure in the cloud. , The digital health ...
Breaking Biology Technology:
Cached News: